1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow 0.1% RO7058584: new trials by email Literature Review of 0.1% RO7058584 trials Research Report on 0.1% RO7058584
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension 0.01% RO7058584, 0.1% RO7058584, 1% RO7058584 - Glaucoma, Open-angle, Ocular Hypertension | Phase 1 | Completed | Hoffmann-La Roche | 27 | 2017-10-10 | 2020-03-31 |
Glaucoma, Open-Angle (1) · Ocular Hypertension (1)
United States (1)